Awards & Announcements

JOil (S) Pte Ltd (“JOil”) is pleased to announce that they have signed a contract with leading Indian plant biotech company KF Bioplants Pvt.Ltd. (“KFB”), a producer and world- wide exporter of more than 40 million ornamental tissue culture plants a year.

Temasek Life Sciences Ventures Pte Ltd (TLV) and Emergent BioSolutions Inc. (NYSE:EBS) today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, crossprotective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.

Temasek Life Sciences Laboratory, German Cluster of Excellence ‘NeuroCure – Towards a better outcome of Neurological diseases’, the German Federal Ministry of Education and Research (BMBF), the German Academic Exchange Service (DAAD), and the National University of Singapore (NUS) are pleased to present the first joint symposium on Neurosciences on 9 November 2009 at Pixel…

Temasek Life Sciences Laboratory Limited (“TLL”) is pleased to announce that one of its spin-off companies, JOil (S) Pte Ltd, has successfully secured a S$5 million investment from Toyota Tsusho Corporation (“TTC”).

Temasek Life Sciences Laboratory Limited (TLL) is pleased to announce the successful development of several key platform technologies related to the biofuel plant, Jatropha curcus, to address current issues confronting the bioenergy industry. These technologies allow TLL to make use of powerful molecular techniques to generate superior Jatropha planting materials with customized traits so that…

Temasek Life Sciences Laboratory (TLL) is pleased to announce that Dr Stephen Cohen will take up appointment as Chief Executive Officer from July 2007. He will succeed Professor William Chia to oversee the research and developmental activities at TLL.

Scientists at Temasek Life Sciences Laboratory (TLL) have identified an important mechanism that may control patterning of the body. This discovery was made by Mr Aniket Gore, who is currently pursuing his PhD with Dr Karuna Sampath, group leader of the Vertebrate Development Group at TLL. Their results are published in the December 15 issue…

The Norwegian company, GenoMar ASA (GenoMar), one of the world’s leading life science companies specializing in aquatic species, has signed a long-term research collaboration with Temasek Lifesciences Laboratory (TLL). The research and development work will be focused on the Nile tilapia (Oreochromis niloticus) and Atlantic salmon (Salmo salar).

Temasek Life Sciences Laboratory (TLL) is pleased to announce that Professor William Chia has been appointed its Executive Director, and will assume his duties early in 2004. In his new appointment, Professor Chia will oversee the research and developmental activities at TLL. He will work closely with TLL’s Scientific Advisory Board to develop TLL into…

Temasek Life Sciences Laboratory (TLL) and Tan Tock Seng Hospital (TTSH) are pleased to announce their successful collaboration in the development of an ELISA (Enzyme-Linked Immunosorbent Assay) for the detection of the Severe Acute Respiratory Syndrome (SARS) infection.

Six healthcare and research companies have joined forces to form the Singapore Dengue Consortium to study the mosquito-borne disease. The six organizations – the Environmental Health Institute (a division of the National Environment Agency), the Genome Institute of Singapore, SingHealth Group, National Healthcare Group, the Novartis Institute for Tropical Diseases and Temasek Life Sciences Laboratory…

Temasek Life Sciences Laboratory (TLL) is pleased to announce the discovery of an important control mechanism functioning in mitosis by Dr Snezhana Oliferenko and Associate Professor Mohan Balasubramanian. Mitosis is a fundamental process of life, which distributes full sets of chromosomes from a parent to two daughter cells.